학술논문

Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo
Document Type
Letter to the editor
Report
Source
Leukemia. May 1, 2016, p1220, 6 p.
Subject
Gene mutations -- Health aspects
Enzyme inhibitors -- Patient outcomes
Genotype -- Health aspects
Language
English
ISSN
0887-6924
Abstract
FLT3-internal-tandem-duplication (ITD)-mutated acute myeloid leukemia (AML) is difficult to treat and the majority of patients experience relapse within a short period of time after discontinuation of chemotherapy. (1) Current therapeutic [...]